Compare AU

Compare CURE vs. ETPMPM

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are CURE and ETPMPM. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

CURE

ETPMPM

Popularity

Low

Low

Pearlers invested

82

16

Median incremental investment

$619.50

$851.61

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$1,894.58

Average age group

> 35

> 35


Key Summary

CURE

ETPMPM

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

ETPMPM.AX was created on 2009-01-02 by Global X. The fund's investment portfolio concentrates primarily on broad market commodities. ETFS Physical Precious Metals Basket (ETPMPM.AX) is designed to offer investors a simple, cost-efficient and secure way to access physical gold, silver, platinum and palladium by providing a return equivalent to the movements in the spot price of the metals less the applicable management fee.

Top 3 holdings

Natera Inc (3.41 %)

Incyte Corp (2.94 %)

Gilead Sciences Inc (2.88 %)

Global X Metal Securities Australia Limited (100 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.45 %

0.44 %


Key Summary

CURE

ETPMPM

Issuer

Global X

Global X

Tracking index

S&P Biotechnology Select Industry

LBMA & LPPM Precious Metals Price PM - Benchmark TR Gross

Asset class

ETF

ETF

Management fee

0.45 %

0.44 %

Price

$49.94

$252.61

Size

$38.065 million

$59.626 million

10Y return

N/A

120.58 %

Annual distribution/ dividend yield (5Y)

4.24 %

- %

Market

ASX

ASX

First listed date

12/11/2018

30/01/2009

Purchase fee

$6.50

$6.50


Community Stats

CURE

ETPMPM

Popularity

Low

Low

Pearlers invested

82

16

Median incremental investment

$619.50

$851.61

Median investment frequency

Monthly

Monthly

Median total investment

$1,323.41

$1,894.58

Average age group

> 35

> 35


Pros and Cons

CURE

ETPMPM

Pros

  • Higher exposure to US market

  • Higher distribution yield

  • Lower management fee

  • Higher price growth

Cons

  • Higher management fee

  • Lower price growth

  • Lower exposure to US market

  • Lower distribution yield

CURE

ETPMPM

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home